Abstract
RECENTLY interest has revived in the activity of the sulphonamides and sulphones against strains of malaria parasites, especially P. falciparum, that are resistant to other drugs such as chloroquine and pyrimethamiiie1. A number of acridine derivatives, including mepacrine, prevent the emergence in vitro of resistance to sulphonamides and certain antibiotics in Staphylococcus spp.2,3. Because mepacrine itself is a potential antimalarial blood schizontocide it seemed of interest to explore whether the simultaneous administration of mepacrine and a sulphonamide in malaria would result in any change in the pattern of development of resistance of the parasites to either drug.
Similar content being viewed by others
References
WHO Tech. Rep. Ser., No. 375 (1967).
Sevag, M. G., Arch. Biochem. Biophys., 108, 85 (1964).
Sevag, M. G., and Ashton, B., Nature, 203, 1323 (1964).
Peters, W., Exp. Parasit., 17, 80 (1965).
Bishop, A., and McConnachie, E. W., Nature, 162, 541 (1948).
Bishop, A., and McConnachie, E. W., Parasitology, 40, 163 (1950).
Ramakrishnan, S. P., Prakash, S., Choudhury, D. S., and Basu, P. C., Indian J. Malar., 15, 95 (1961).
Peters, W., Nature, 208, 693 (1965).
Arai, T., and Watanabe, T., Genet. Res., 10, 241 (1967).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
PETERS, W. Partial Inhibition by Mepacrine of the Development of Sulphonamide Resistance in Plasmodium berghei. Nature 223, 858–859 (1969). https://doi.org/10.1038/223858b0
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1038/223858b0
- Springer Nature Limited